Table 1 Characteristics of studies included in the present meta-analysis.

From: Is overexpression of TWIST, a transcriptional factor, a prognostic biomarker of head and neck carcinoma? Evidence from fifteen studies

First Author

Year

Number of Patients

Cut-off of IHC

Method of quantification

Hazard ratio (95% CI)

site

Area

Outcome

total

TWIST negative or low

TWIST positive or high

Song

2006

75

42

33

≥ 5%

Percentage of staining

1.50 (1.05–5.01)*

Nasopharynx

China

(2) (3) (4) (5) (6) (11) (12)

Ou

2008

50

30

20

NA

NA

Combined

China

(1) (2) (3) (4) (5)

Gasparotto

2011

68

34

34

NA

NA

2.18 (1.08–4.41)

Combined

Italy

(5) (11)

Huang

2011

80

27

53

≥ 5%

Percentage of staining

Larynx

China

(1) (2) (4) (5) (6) (7) (12)

Liang

2011

89

49

40

≥ 5%

Percentage of staining

3.06 (1.36–6.89)*

Oral

China

(1) (2) (3) (4) (5) (8) (9) (10) (11)

Lu

2011

66

22

44

NA

Percentage of staining

Larynx

China

(1) (2) (5) (6)

Gong

2012

62

14

48

≥ 5%

Percentage of staining

Oral

China

(1) (2) (4) (5) (6) (7)

Wang

2012

60

30

30

≥ 4

Sum of percentage and intensity

Oral

China

(1) (2) (3) (4) (5)

Wushou

2012

60

18

42

≥ 3

Sum of percentage and intensity

4.65 (1.06–20.45)

Oral

China

(1) (2) (3) (4) (5) (6) (7) (8) (9) (11)

Zheng

2012

69

20

49

≥ 1

Sum of percentage and intensity

Oral

China

(1) (2) (4) (5) (6) (7)

Fan

2013

114

40

74

≥ 2

Sum of percentage and intensity

0.89 (0.52–1.51)

Oral

China

(1) (2) (3) (4) (5) (6) (7) (8) (9) (11)

Hu

2013

60

19

41

≥ 10%

Percentage of staining

Larynx

China

(1) (2) (4) (5) (6) (7) (12)

da Silva

2014

52

30

22

> 2

Extent of staining

4.28 (1.03–61.12)*

Oral

Brazil

(3) (4) (5) (10) (11)

Qian

2014

81

34

47

≥ 30%

Percentage of staining

Combined

Germany

(1) (2) (3) (4) (5) (8) (9)

Zhu

2014

49

19

30

4–12

Sum of percentage and intensity

Larynx

China

(1) (4) (5) (6) (7)

  1. Clinical features: (1) Age; (2) Gender ; (3) T stage; (4) Differentiation; (5) Lymph node metastasis; (6) Clinical stage; (7) The control benign tissue; (8) Smoking; (9) Drinking. (10) Local recurrence; (11) Survival analysis (12) Distant metastasis.
  2. *Estimated from the Kaplan-Meier curves in the text.
  3. NA: Not available.